(firstQuint)A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours.

 The purpose of this study is to find out what effects the study drugs - sunitinib or temsirolimus - will have on this type of cancer.

 The study will begin by finding out if sunitinib can shrink the cancer.

 If sunitinib does not work, temsirolimus will be tested next.

.

 A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours@highlight

This research is being done because there is no treatment that will cure this type of cancer.

 Although some types of chemotherapy can cause this cancer to shrink for a time, better options are needed.

